Gracell Biotechnologies Inc - ADR
Gracell Biotechnologies Inc - ADR Stock, NASDAQ:GRCL
Gracell Biotechnologies Co. Ltd. engages in the research and development activities of biotechnological and pharmaceutical industries. The firm through its FasTCAR and TruUCAR platforms, it is developing a pipeline of autologous and allogeneic cell therapy candidates with the potential to treat both hematologic malignancies and solid tumors. The company was founded by William Wei Cao in 2017 and is headquartered in Suzhou, China.